|
ZNF280D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.3241855368924E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12259998466635E-09 |
| Normal-vs-Stage2 |
3.19209999988246E-07 |
| Normal-vs-Stage3 |
2.47170062195323E-11 |
| Normal-vs-Stage4 |
1.66320002215059E-09 |
| Stage1-vs-Stage2 |
3.407600E-01 |
| Stage1-vs-Stage3 |
2.178000E-02 |
| Stage1-vs-Stage4 |
5.487800E-02 |
| Stage2-vs-Stage3 |
5.052800E-01 |
| Stage2-vs-Stage4 |
4.689400E-01 |
| Stage3-vs-Stage4 |
8.821000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.180278097479E-12 |
| Normal-vs-AfricanAmerican |
3.830100E-04 |
| Normal-vs-Asian |
1.241890E-04 |
| Caucasian-vs-AfricanAmerican |
4.619400E-01 |
| Caucasian-vs-Asian |
1.525160E-01 |
| AfricanAmerican-vs-Asian |
7.864000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.40950000004914E-07 |
| Normal-vs-Female |
2.43516318221282E-12 |
| Male-vs-Female |
1.325160E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.87020004932737E-09 |
| Normal-vs-Age(41-60Yrs) |
2.65219957107377E-10 |
| Normal-vs-Age(61-80Yrs) |
1.73210001896962E-09 |
| Normal-vs-Age(81-100Yrs) |
1.62859999996989E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.039600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.472600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.306200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.490600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.148600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.832600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.043380E-04 |
| Classical-VS-Follicular |
3.860200E-01 |
| Classical-VS-Other |
1.904360E-01 |
| Classical-VS-Normal |
4.87589968400925E-11 |
| Tall-VS-Follicular |
1.575420E-04 |
| Tall-VS-Other |
4.859600E-02 |
| Tall-VS-Normal |
2.04447569984723E-12 |
| Follicular-VS-Other |
4.369800E-01 |
| Follicular-VS-Normal |
2.33609999999995E-05 |
| Other-VS-Normal |
2.183200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.65240110062382E-11 |
| Normal-vs-N1 |
3.5030000000047E-05 |
| N0-vs-N1 |
6.732400E-01 |
|
|
